Sales for the quarter ended at MNOK 74.4 (MNOK 65.5), an
increase of 13.5 %. Currency neutral growth of own products
was 20.3 %. Operating profit (EBIT) ended at MNOK 16.0 (MNOK
13.5), up 18.4 %. Sales from the US continues to grow and
increased with 9.6 % in USD. Medistim established a sales
organization through a new subsidiary in Spain during the
first quarter. The General Meeting decided to pay a
dividend of NOK 1.75 per share.